Company record
ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC)
Signals
5 on record
- EPO patentsPatent
Patent publication WO2026230996A1 by ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC): A PROPHYLACTIC TREATMENT OF CANCER.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication WO2026230995A1 by ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC): MODIFIED HYPOIMMUNOGENIC STEM CELLS.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication NL2040080B1 by ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC): Ubiquitin Vaccine Components.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication US20260306599A1 by ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC): TIMP3-DERIVED TEIPP NEOANTIGENS AND USES THEREOF.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication WO2026206152A1 by ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC): UBIQUITIN VACCINE COMPONENTS.
EPO patentsRelevance21
Watch · 80% confidence